Steris (STE) Cash from Investing Activities (2018 - 2026)
Steris' (STE) quarterly Cash from Investing Activities came in at -$217.2 million in Q1 2026, down 211.17% year-on-year from $195.4 million in Q1 2025, and down 120.51% quarter-over-quarter from -$98.5 million in Q4 2025.
Steris (STE) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Steris' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$217.2 million for Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 211.17% year-over-year to -$217.2 million in Q1 2026; TTM through Mar 2026 was -$512.5 million, a 231.82% decrease from a year earlier, with the FY2026 full-year figure at -$512.5 million, down 231.82% from the prior year.
- Cash from Investing Activities eased to -$217.2 million in Q1 2026 per STE's latest filing, from -$98.5 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $687.8 million in Q2 2024 and bottomed at -$606.2 million in Q3 2023.
- The 5-year median for Cash from Investing Activities is -$98.4 million (2022), against an average of -$76.5 million.
- Across the five-year window, Cash from Investing Activities tumbled 519.08% in 2023 and soared 1132.79% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at -$98.4 million in 2022, then retreated by 20.84% to -$118.9 million in 2023, then dropped by 4.19% to -$123.9 million in 2024, then advanced by 20.5% to -$98.5 million in 2025, then sank by 120.51% to -$217.2 million in 2026.
- Per Business Quant, the three latest STE Cash from Investing Activities figures stand at -$217.2 million (Q1 2026), -$98.5 million (Q4 2025), and -$88.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Steris | 21.44 Bn | 21.00 Bn | 697.10 Mn | -217.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -217.20 Mn |
| Mar 31, 2026 | -217.20 Mn |
| Dec 31, 2025 | -98.50 Mn |
| Dec 31, 2025 | -98.50 Mn |
| Sep 30, 2025 | -88.30 Mn |
| Sep 30, 2025 | -88.30 Mn |
| Jun 30, 2025 | -108.50 Mn |
| Jun 30, 2025 | -108.50 Mn |
| Mar 31, 2025 | -69.80 Mn |
| Mar 31, 2025 | -69.80 Mn |
| Dec 31, 2024 | -123.90 Mn |
| Dec 31, 2024 | -123.90 Mn |
| Sep 30, 2024 | -105.30 Mn |
| Sep 30, 2024 | -105.30 Mn |
| Jun 30, 2024 | 687.80 Mn |
| Jun 30, 2024 | 687.80 Mn |
| Mar 31, 2024 | -95.65 Mn |
| Mar 31, 2024 | -95.65 Mn |
| Dec 31, 2023 | -118.92 Mn |
| Dec 31, 2023 | -118.92 Mn |